141 related articles for article (PubMed ID: 12837155)
1. Positron emission tomography in the management of patients with indolent non-Hodgkin's lymphoma.
Naumann R; Beuthien-Baumann B
Clin Lymphoma; 2003 Jun; 4(1):50-1. PubMed ID: 12837155
[No Abstract] [Full Text] [Related]
2. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.
Wirth A; Seymour JF; Hicks RJ; Ware R; Fisher R; Prince M; MacManus MP; Ryan G; Januszewicz H; Wolf M
Am J Med; 2002 Mar; 112(4):262-8. PubMed ID: 11893364
[TBL] [Abstract][Full Text] [Related]
3. Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma.
Blum RH; Seymour JF; Wirth A; MacManus M; Hicks RJ
Clin Lymphoma; 2003 Jun; 4(1):43-9. PubMed ID: 12837154
[TBL] [Abstract][Full Text] [Related]
4. Stage IE non-Hodgkin's thyroid lymphoma on (18)F-FDG-PET/CT.
Mehta A; Muthukrishnan A
Hell J Nucl Med; 2011; 14(2):186-7. PubMed ID: 21761029
[No Abstract] [Full Text] [Related]
5. Early restaging positron emission tomography with 18F-fluorodeoxyglucose in aggressive non-Hodgkin's lymphomas: is it too easy to be true?
Balzarotti M; Magagnoli M; Santoro A
Ann Oncol; 2003 Jul; 14(7):1155-6. PubMed ID: 12853364
[No Abstract] [Full Text] [Related]
6. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.
Even-Sapir E; Lievshitz G; Perry C; Herishanu Y; Lerman H; Metser U
Radiol Clin North Am; 2007 Jul; 45(4):697-709, vii. PubMed ID: 17706534
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography for detection and staging of malignant lymphoma.
Buchmann I; Moog F; Schirrmeister H; Reske SN
Recent Results Cancer Res; 2000; 156():78-89. PubMed ID: 10802866
[TBL] [Abstract][Full Text] [Related]
8. False-positive F-18 FDG gamma camera positron emission tomographic imaging resulting from inflammation of an anterior mediastinal mass in a patient with non-Hodgkin's lymphoma.
Yoon SN; Park CH; Kim MK; Hwang KH; Kim S
Clin Nucl Med; 2001 May; 26(5):461-2. PubMed ID: 11317035
[No Abstract] [Full Text] [Related]
9. Comparison of CT, PET, and PET/CT for staging of patients with indolent non-hodgkin's lymphoma: statistical errors in Fueger et al. (2009).
White LR
Mol Imaging Biol; 2012 Aug; 14(4):397-8; author reply 399-401. PubMed ID: 21814856
[No Abstract] [Full Text] [Related]
10. Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL.
Jerusalem GH; Beguin YP
Clin Lymphoma; 2002 Jun; 3(1):56-61. PubMed ID: 12141957
[TBL] [Abstract][Full Text] [Related]
11. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.
Schöder H; Noy A; Gönen M; Weng L; Green D; Erdi YE; Larson SM; Yeung HW
J Clin Oncol; 2005 Jul; 23(21):4643-51. PubMed ID: 15837966
[TBL] [Abstract][Full Text] [Related]
12. Fluorine-18 fluorodeoxyglucose positron emission tomography for lymphoma: incorporating new technology into clinical care.
Kaplan LD
Am J Med; 2002 Mar; 112(4):320-1. PubMed ID: 11893374
[No Abstract] [Full Text] [Related]
13. The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.
Chiusolo P; Sica S; Leone G
Hematology; 2003 Dec; 8(6):403-8. PubMed ID: 14668036
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT in a case of bilateral lacrimal gland infiltration by mantle cell lymphoma.
Martínez-Esteve A; García-Gómez FJ; Borrero-Martin JJ; Fajardo-Pico E; Borrego-Dorado I
Rev Esp Med Nucl Imagen Mol; 2015; 34(6):396-7. PubMed ID: 25956958
[No Abstract] [Full Text] [Related]
15. Hodgkin's and non-Hodgkin's lymphomas.
Rademaker J
Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624
[TBL] [Abstract][Full Text] [Related]
16. F-18 FDG positron emission tomography in primary breast non-Hodgkin's lymphoma.
Bakheet SM; Bakheet R; Ezzat A; Tulbah A; Durakovic A; Hussain S
Clin Nucl Med; 2001 Apr; 26(4):299-301. PubMed ID: 11290887
[TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin's lymphoma of the bone can mimic osteomyelitis on FDG PET.
Chamroonrat W; Houseni M; Bing Z; Yang H; Alavi A; Zhuang H
Clin Nucl Med; 2007 Mar; 32(3):252-4. PubMed ID: 17314615
[No Abstract] [Full Text] [Related]
18. Commentary: PET poised to alter the current paradigm for response assessment of non-Hodgkin's lymphoma.
Guermazi A; Juweid ME
Br J Radiol; 2006 May; 79(941):365-7. PubMed ID: 16632614
[No Abstract] [Full Text] [Related]
19. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.
Delbeke D; Stroobants S; de Kerviler E; Gisselbrecht C; Meignan M; Conti PS
Oncologist; 2009; 14 Suppl 2():30-40. PubMed ID: 19819922
[TBL] [Abstract][Full Text] [Related]
20. Images in cardiovascular medicine. Metabolic imaging identifies non-Hodgkin's lymphoma infiltrating heart.
Römer W; Garbrecht M; Fuchs C; Schwaiger M
Circulation; 1998 Jun; 97(25):2577-8. PubMed ID: 9657480
[No Abstract] [Full Text] [Related]
[Next] [New Search]
